NurOwn (MSC-NTF autologous cell therapy)

autologous mesenchymal stromal cells secreting neurotrophic factors · Brainstorm-Cell Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NurOwn (MSC-NTF autologous cell therapy), covering 2018-03-08 to 2018-03-08. Get the full timeline:

Most recent: Clinical Trial Update: Autologous Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in Patients With Amyotrophic Lateral Sclerosis (ALS) [Phase 2]

See pricing